Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy.

Clark RAF, Fenner J, Sasson A, McClain SA, Singer AJ, Tonnesen MG.

Exp Dermatol. 2018 Jun;27(6):625-629. doi: 10.1111/exd.13518. Epub 2018 Apr 10.

PMID:
29478253
2.

Blood vessel occlusion in peri-burn tissue is secondary to erythrocyte aggregation and mitigated by a fibronectin-derived peptide that limits burn injury progression.

Asif B, Rahim A, Fenner J, Lin F, Hirth D, Hassani J, McClain SA, Singer AJ, Tonnesen MG, Clark RA.

Wound Repair Regen. 2016 May;24(3):501-13. doi: 10.1111/wrr.12430. Epub 2016 Apr 28.

PMID:
27027391
3.

Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.

Snedecor ER, Sung CC, Moncayo A, Rothstein BE, Mockler DC, Tonnesen MG, Jones EC, Fujita M, Clark RA, Shroyer KR, Chen J.

J Invest Dermatol. 2015 May;135(5):1456-1458. doi: 10.1038/jid.2015.22. Epub 2015 Jan 28. No abstract available.

4.

Fibronectin peptides that bind PDGF-BB enhance survival of cells and tissue under stress.

Lin F, Zhu J, Tonnesen MG, Taira BR, McClain SA, Singer AJ, Clark RAF.

J Invest Dermatol. 2014 Apr;134(4):1119-1127. doi: 10.1038/jid.2013.420. Epub 2013 Oct 14.

5.

Fibrin and collagen differentially but synergistically regulate sprout angiogenesis of human dermal microvascular endothelial cells in 3-dimensional matrix.

Feng X, Tonnesen MG, Mousa SA, Clark RA.

Int J Cell Biol. 2013;2013:231279. doi: 10.1155/2013/231279. Epub 2013 Apr 30.

6.

Curcumin myths or wonders? A systematic analysis of in vitro studies.

Harsono D, Finelt N, Castano EB, Tonnesen MG, Clark RA.

Wound Repair Regen. 2013 Mar-Apr;21(2):335-6. doi: 10.1111/wrr.12019. Review. No abstract available.

PMID:
23464635
7.

Fibronectin growth factor-binding domains are required for fibroblast survival.

Lin F, Ren XD, Pan Z, Macri L, Zong WX, Tonnesen MG, Rafailovich M, Bar-Sagi D, Clark RA.

J Invest Dermatol. 2011 Jan;131(1):84-98. doi: 10.1038/jid.2010.253. Epub 2010 Sep 2.

8.

Tissue engineering for cutaneous wounds.

Clark RA, Ghosh K, Tonnesen MG.

J Invest Dermatol. 2007 May;127(5):1018-29. Review.

9.

Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair.

Kubo M, Van de Water L, Plantefaber LC, Mosesson MW, Simon M, Tonnesen MG, Taichman L, Clark RA.

J Invest Dermatol. 2001 Dec;117(6):1369-81. Erratum in: J Invest Dermatol 2002 May;118(5):910.

10.

Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading.

Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B.

J Immunol. 2002 Mar 1;168(5):2441-8.

11.

Angiogenesis in wound healing.

Tonnesen MG, Feng X, Clark RA.

J Investig Dermatol Symp Proc. 2000 Dec;5(1):40-6. Review.

12.
13.

Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.

Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL.

J Clin Invest. 1997 Jun 1;99(11):2691-700.

14.

Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3.

Gailit J, Clarke C, Newman D, Tonnesen MG, Mosesson MW, Clark RA.

Exp Cell Res. 1997 Apr 10;232(1):118-26.

PMID:
9141628
15.

Mesenchymal cell activation is the rate-limiting step of granulation tissue induction.

McClain SA, Simon M, Jones E, Nandi A, Gailit JO, Tonnesen MG, Newman D, Clark RA.

Am J Pathol. 1996 Oct;149(4):1257-70.

16.

Transient functional expression of alphaVbeta 3 on vascular cells during wound repair.

Clark RA, Tonnesen MG, Gailit J, Cheresh DA.

Am J Pathol. 1996 May;148(5):1407-21.

17.

Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression.

Meng H, Tonnesen MG, Marchese MJ, Clark RA, Bahou WF, Gruber BL.

J Cell Physiol. 1995 Oct;165(1):40-53.

PMID:
7559805
18.

Case report: an unusual reaction to foods?

Oppenheimer JJ, Tonnesen MG, Nelson HS.

Ann Allergy. 1992 Jan;68(1):17-21. No abstract available.

PMID:
1736715
19.

Interaction between chemoattractants and bacterial lipopolysaccharide in the induction and enhancement of neutrophil adhesion.

Young SK, Worthen GS, Haslett C, Tonnesen MG, Henson PM.

Am J Respir Cell Mol Biol. 1990 Jun;2(6):523-32.

PMID:
2189456
20.

Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium.

Tonnesen MG.

J Invest Dermatol. 1989 Aug;93(2 Suppl):53S-58S. Review.

PMID:
2666523
22.
23.

Effects of shear stress on adhesive interaction between neutrophils and cultured endothelial cells.

Worthen GS, Smedly LA, Tonnesen MG, Ellis D, Voelkel NF, Reeves JT, Henson PM.

J Appl Physiol (1985). 1987 Nov;63(5):2031-41.

PMID:
3693234
24.

Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne.

Norris DA, Osborn R, Robinson W, Tonnesen MG.

J Invest Dermatol. 1987 Jul;89(1):38-43.

25.

Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.

Doherty DE, Haslett C, Tonnesen MG, Henson PM.

J Immunol. 1987 Mar 15;138(6):1762-71.

PMID:
3819394
26.

Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Smedly LA, Tonnesen MG, Sandhaus RA, Haslett C, Guthrie LA, Johnston RB Jr, Henson PM, Worthen GS.

J Clin Invest. 1986 Apr;77(4):1233-43.

27.

Expression of fibronectin, laminin, and factor VIII-related antigen during development of the human cutaneous microvasculature.

Tonnesen MG, Jenkins D Jr, Siegal SL, Lee LA, Huff JC, Clark RA.

J Invest Dermatol. 1985 Dec;85(6):564-8.

29.

Detection of a herpes simplex viral antigen in skin lesions of erythema multiforme.

Orton PW, Huff JC, Tonnesen MG, Weston WL.

Ann Intern Med. 1984 Jul;101(1):48-50.

PMID:
6329053
30.

Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme.

Margolis RJ, Tonnesen MG, Harrist TJ, Bhan AK, Wintroub BU, Mihm MC Jr, Soter NA.

J Invest Dermatol. 1983 Nov;81(5):403-6.

31.

Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes.

Huff JC, Weston WL, Tonnesen MG.

J Am Acad Dermatol. 1983 Jun;8(6):763-75. Review.

PMID:
6345608
32.

Erythema multiforme: microvascular damage and infiltration of lymphocytes and basophils.

Tonnesen MG, Harrist TJ, Wintroub BU, Mihm MC Jr, Soter NA.

J Invest Dermatol. 1983 Apr;80(4):282-6.

33.

The microvasculature in inflammation.

Tonnesen MG, Smedly L, Goins A, Henson PM.

Agents Actions Suppl. 1982;11:25-38.

PMID:
6960652
34.

Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

Tonnesen MG, Klempner MS, Austen KF, Wintroub BU.

J Clin Invest. 1982 Jan;69(1):25-30.

35.

Erythema multiforme.

Tonnesen MG, Soter NA.

J Am Acad Dermatol. 1979 Oct;1(4):357-64.

PMID:
512083
36.

Circadian variation of prostaglandin E(PGE) production in human gastric juice.

Tonnesen MG, Jubiz W, Moore JG, Frailey J.

Am J Dig Dis. 1974 Jul;19(7):644-8. No abstract available.

PMID:
4835334

Supplemental Content

Loading ...
Support Center